FibriCheck

FibriCheck is a digital health company established in 2014, specializing in the development of medical-grade mobile apps, including the CE-certified FibriCheck, designed to identify heart rhythm disorders. The company's mission revolves around creating accessible, user-friendly, and cost-effective mobile medical applications to enhance health outcomes. Their flagship product, FibriCheck, has gained recognition as a Class IIa CE-certified diagnostic solution that utilizes smartphone cameras for the detection of heart rhythm disorders such as atrial fibrillation, extending beyond the confines of clinical settings. FibriCheck recently secured a significant €9.00M Venture Round investment on 30 December 2020. The investment was backed by Volta Ventures and Limburgse Reconversie Maatschappij, signifying a strong vote of confidence from the investor community in the potential and effectiveness of FibriCheck's innovative solutions. The company operates within the Information Technology and Mobile industries, positioned at the forefront of leveraging mobile technology for healthcare advancements. FibriCheck's dedication to driving accessible and innovative healthcare through mobile applications is reflected in its commitment to making medical solutions more efficient and widespread. With their recent investment and pioneering product offerings, FibriCheck is poised to make significant contributions to the evolving landscape of digital health.